By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
en English
en Englishja 日本語ko 한국어
Times of JapanTimes of Japan
Notification Show More
Latest News
Top U.S. diplomat to visit Beijing for long-awaited talks on June 18
Published June 10, 2023
Japan’s Revised Immigration Law Aims to Prevent Abuse of Refugee Application System
Published June 10, 2023
Documents in Trump indictment were among nation’s most closely guarded
Published June 10, 2023
Major Japan firms expect FY2023 net profit to rise 4% to record high
Published June 10, 2023
Passenger planes make contact on taxiway at Tokyo’s Haneda Airport
Published June 10, 2023
Aa
  • Home
  • News
  • Politics
  • World
  • Society
  • Business
  • Culture
  • Science
  • Technology
  • Sports
Reading: Shionogi confirms efficacy of oral COVID drug for omicron subvariant
Share
Times of JapanTimes of Japan
Aa
  • News
  • World
  • Politics
  • Society
  • Business
  • Culture
  • Science
  • Technology
  • Sports
Search
  • Home
  • News
  • Politics
  • World
  • Society
  • Business
  • Culture
  • Science
  • Technology
  • Sports
Have an existing account? Sign In
Follow US
Times of Japan > News > Shionogi confirms efficacy of oral COVID drug for omicron subvariant
News

Shionogi confirms efficacy of oral COVID drug for omicron subvariant

Staff
Staff Published August 10, 2022
Last updated: 2022/08/10 at 7:25 AM
Share
SHARE

Osaka – Japanese pharmaceutical firm Shionogi & Co. said Wednesday its oral COVID-19 drug currently under development has been confirmed in preclinical testing to be effective against the omicron subvariant BA.2.75, which has been detected in Japan.

The announcement came after a health ministry panel in July postponed the granting of emergency approval for the drug. Discussions are slated to resume after the results of the final stage of clinical trials currently underway.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this support page.

We humbly apologize for the inconvenience.

Staff August 10, 2022
Share this Article
Facebook TwitterEmail Print
Share
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

You Might Also Like

News

Top U.S. diplomat to visit Beijing for long-awaited talks on June 18

Published June 10, 2023
News

Documents in Trump indictment were among nation’s most closely guarded

Published June 10, 2023
News

Major Japan firms expect FY2023 net profit to rise 4% to record high

Published June 10, 2023
News

Passenger planes make contact on taxiway at Tokyo’s Haneda Airport

Published June 10, 2023
  • National
  • International
  • Politics
  • Insider
  • Science
  • Privacy Policy
  • Terms of use
  • Contact

© 2022 Times of Japan. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?